Dashboard
Manage Tickers

NPCE NeuroPace Inc

Nasdaq www.neuropace.com


$ 10.74 $ 0.33 (3.17 %)    

Monday, 20-Oct-2025 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.11 $ 7.61 (1.26 %)
DIA $ 467.12 $ 5.24 (1.13 %)
SPY $ 671.75 $ 6.91 (1.04 %)
TLT $ 91.68 $ 0.35 (0.38 %)
GLD $ 401.36 $ 14.16 (3.64 %)
$ 10.74
$ 10.52
$ 10.10 x 97
$ 11.20 x 2
$ 10.50 - $ 10.90
$ 5.45 - $ 18.98
151,679
na
355.3M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-04-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-05-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-02-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 06-03-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-neuropace-lowers-price-target-to-15
Wells Fargo Maintains Overweight on NeuroP...
08/13/2025 12:42:08

Wells Fargo analyst Vik Chopra maintains NeuroPace (NASDAQ:NPCE) with a Overweight and lowers the price target from $17 to $15.

neuropace-raises-fy2025-sales-guidance-from-9300m-9700m-to-9400m-9800m-vs-9482m-est
NeuroPace Raises FY2025 Sales Guidance fro...
08/12/2025 20:08:57

NeuroPace (NASDAQ:NPCE) raises FY2025 sales outlook from $93.00 million-$97.00 million to $94.00 million-$98.00 million vs $94....

neuropace-q2-eps-026-misses-023-estimate-sales-2352m-beat-2309m-estimate
NeuroPace Q2 EPS $(0.26) Misses $(0.23) Es...
08/12/2025 20:08:19

NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.23) b...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

neuropace-applauds-cms-decision-to-maintain-reimbursement-for-rns-system-in-fy-2026-rule
NeuroPace Applauds CMS Decision to Maintai...
08/01/2025 11:32:28

NeuroPace, Inc. (NASDAQ:NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, t...

neuropace-appoints-patrick-f-williams-as-cfo-effective-june-20-2025
NeuroPace Appoints Patrick F. Williams As ...
06/24/2025 20:06:25

neuropace-secures-75m-credit-facility-with-midcap-financial-to-strengthen-liquidity
NeuroPace Secures $75M Credit Facility Wit...
06/04/2025 20:11:59

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today...

benzinga-bulls-and-bears-nvidia-palantir-marvell-technology--and-markets-rallied-in-may
Benzinga Bulls And Bears: Nvidia, Palantir...
05/31/2025 12:04:41

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
05/30/2025 12:08:22

analyst-expectations-for-neuropaces-future
Analyst Expectations For NeuroPace's Future
05/28/2025 12:00:53

this-arista-networks-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Arista Networks Analyst Begins Covera...
05/28/2025 11:43:44

hc-wainwright--co-initiates-coverage-on-neuropace-with-buy-rating-announces-price-target-of-18
HC Wainwright & Co. Initiates Coverage On ...
05/28/2025 10:27:01

HC Wainwright & Co. analyst Yi Chen initiates coverage on NeuroPace (NASDAQ:NPCE) with a Buy rating and announces Price ...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/27/2025 17:05:52

why-is-neuropace-stock-falling-after-epilepsy-treatment-study-data
Why Is NeuroPace Stock Falling After Epile...
05/27/2025 16:48:38

NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA...

dow-surges-over-600-points-us-durable-goods-orders-fall-in-april
Dow Surges Over 600 Points; US Durable Goo...
05/27/2025 16:24:41

nasdaq-jumps-over-300-points-on-eu-tariff-delay-autozone-posts-downbeat-earnings
Nasdaq Jumps Over 300 Points On EU Tariff ...
05/27/2025 14:20:47

neuropace-reaffirms-its-previously-issued-full-year-2025-financial-guidance
Neuropace Reaffirms Its Previously Issued ...
05/27/2025 12:19:46

neuropace-announces-preliminary-primary-endpoint-1-yr-results-of-two-year-nautilus-study-evaluating-safety-and-effectiveness-of-rns-system-for-treatment-of-individuals-with-drug-resistant-ige
NeuroPace Announces Preliminary Primary En...
05/27/2025 12:12:04

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluat...

jp-morgan-maintains-overweight-on-neuropace-raises-price-target-to-16
JP Morgan Maintains Overweight on NeuroPac...
05/14/2025 17:03:38

JP Morgan analyst Robbie Marcus maintains NeuroPace (NASDAQ:NPCE) with a Overweight and raises the price target from $14 to ...

tower-semiconductor-posts-upbeat-earnings-joins-nutex-health-kornit-digital-tencent-music-entertainment-and-other-big-stocks-moving-higher-on-wednesday
Tower Semiconductor Posts Upbeat Earnings,...
05/14/2025 16:04:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION